Adaptation of a real-time PCR method for the detection and quantification of pathogenic leptospires in environmental water

Leptospirosis is a major zoonotic disease that affects humans and animals in all continents, in both rural and urban areas. In Europe, metropolitan France is the most affected country, with about 300 human cases declared per year. In France, although leptospirosis is now mostly considered as a recreational disease related to freshwater areas, isolation of pathogenic leptospires from environmental water samples still remains difficult. It thus seemed important to set up an efficient method to detect and quantify these bacteria in this environment. We determined a DNA extraction method suitable for freshwater samples and adapted a real-time quantitative PCR based on the detection of the LipL32 gene using the SYBR green chemistry. The method developed is specific for pathogenic Leptospira. It permits the detection of all the pathogenic strains tested and none of the saprophytic strains. Quantification is possible between 10 and 10(7) bacteria/mL, and therefore, the method represents a tool that could be integrated into future public health surveillance programs for recreational freshwater areas.

Are water vole resistant to anticoagulant rodenticides following field treatments?

The anti-vitamin Ks (AVKs) are widely used to control rodent populations. They inhibit Vitamin K regeneration by the Vitamin K Epoxide Reductase (VKOR) and cause a fatal hemorrhagic syndrome. Because of repeated use, some populations of commensal rodents have expressed resistance to these compounds. In Franche-Comté (France), the water vole exhibits cyclic population outbreaks. A second generation AVK, bromadiolone, has been used for the last 20 years to control vole populations. The aim of this study is to determine whether these repeated treatments could have led to the development of resistance to AVKs in water vole populations. We conducted enzymatic and genetic studies on water voles trapped in treated and non treated plot. The results indicate that voles from the most heavily treated area exhibit enzymatic changes in VKOR activity hence arguing for resistance to AVKs and that an intronic haplotype on the vkorc1 gene seems to be associated with these enzymatic changes.

Assessment of ruminal degradation, oral bioavailability, and toxic effects of anticoagulant rodenticides in sheep

OBJECTIVE

To assess the rate and extent of ruminal degradation of warfarin, chlorophacinone, and bromadiolone in vitro and determine the oral availability and clinical and hemostatic effects of each anticoagulant rodenticide in adult sheep.

ANIMALS

3 Texel sheep.

PROCEDURE

Samples of ruminal fluid were incubated with each of the anticoagulants to assess the kinetics of ruminal degradation over 24 hours. To determine the plasma kinetics of the anticoagulants, each sheep received each of the anticoagulants IV or via a rumenimplanted cannula at 2-month intervals (3 rodenticide exposures/sheep). At intervals during a 240- to 360- hour period after treatment, prothrombin time (PT) was measured, plasma anticoagulant concentration was assessed, and clinical signs of rodenticide poisoning were monitored. In plasma and rumen extracts, anticoagulant concentrations were determined via high-performance liquid chromatography.

RESULTS

In the rumen extracts, anticoagulants were slightly degraded (< 15%) over 24 hours. In vivo, oral availability of warfarin, chlorophacinone, and bromadiolone was estimated at 79%, 92%, and 88%, respectively. Although maximum PT was 80 seconds after chlorophacinone and bromadiolone treatments, no clinical signs of toxicosis were detected; PT returned to baseline values within 2 weeks.

CONCLUSIONS AND CLINICAL RELEVANCE

In sheep, warfarin, chlorophacinone, and bromadiolone were not degraded in the rumen but their bioavailabilities were high after oral administration; the kinetics of these compounds in sheep and other mammals are quite similar. These data suggest that the lack of susceptibility of ruminants to these anticoagulant rodenticides cannot be explained by either ruminal degradation or the specific toxicokinetics of these anticoagulants.

EVIDENCE OF SECONDARY POISONING OF FREE-RANGING RIPARIAN MUSTELIDS BY ANTICOAGULANT RODENTICIDES IN FRANCE: IMPLICATIONS FOR CONSERVATION OF EUROPEAN MINK (MUSTELA LUTREOLA)

Because of the rapid decline of the endangered European mink (Mustela lutreola) populations in France, a national conservation program has been put into action, including research to understand the causes of decline. As part of this research, concentrations of eight anticoagulant rodenticides were examined in livers from 122 carcasses of four species of free-ranging mustelids collected between 1990 and 2002 in southwestern France. Bromadiolone residue was found in all species and 9% of the sample (one of 31 European mink, three of 47 American mink [Mustela vison], five of 33 polecats [Mustela putorius], and two of 11 European otters [Lutra lutra]). Liver concentrations ranged from 0.6 mug/g to 9.0 mug/g. Chlorophacinone residue was found in two species and 4% of the sample (in four of the American mink and in one of the otters), with liver concentrations ranging from 3.4 mug/g to 8.5 mug/g. Two polecats and one American mink had lesions and liver residues indicating bromadiolone was directly responsible for their death. However, most of our study animals survived secondary poisoning until they were caught; this study certainly underestimates the extent of fatal exposure of mustelids to rodenticides. Moreover, anticoagulant poisoning could increase their vulnerability to other causes of death. The current status of the endangered European mink population is such that any additional risk factor for mortality is important, and it is thus urgent to monitor and reduce the extensive use of bromadiolone and chlorophacinone against field rodents in France.

Field evidence of secondary poisoning of foxes (Vulpes vulpes) and buzzards (Buteo buteo) by bromadiolone, a 4-year survey

This paper presents the result of a 4 year survey in France (1991-1994) based on the activity of a wildlife disease surveillance network (SAGIR). The purpose of this study was to evaluate the detrimental effects of anticoagulant (Ac) rodenticides in non-target wild animals. Ac poisoning accounted for a very limited number of the identified causes of death (1-3%) in most species. Predators (mainly foxes and buzzards) were potentially exposed to anticoagulant compounds (especially bromadiolone) via contaminated prey in some instances. The liver concentrations of bromadiolone residues were elevated and species-specific diagnostic values were determined. These values were quite similar to those reported in the literature when secondary anticoagulant poisoning was experimentally assessed.

Toxicity and kinetics of amitraz in dogs

OBJECTIVE

To evaluate the toxic effects of amitraz in dogs and their reversal by various doses of atipamezole.

ANIMALS

6 male 1-year-old Beagles.

PROCEDURE

Dogs were given 100 mg of amitraz/kg of body weight, PO. Atipamezole was administered at 3 dose rates. Clinical examination and blood sample collection were performed regularly for 48 hours to examine biological parameters and determine the toxicokinetics of amitraz as well as the efficacy of the antidote. A specific high-performance thin layer chromatographic method was developed to determine plasma amitraz concentrations.

RESULTS

Clinical signs of toxicosis included sedation, bradycardia, polyuria, hypothermia, and hyperglycemia, all of which could be related to the alpha 2-agonist activity of amitraz, and were reversed by low doses of atipamezole (50 micrograms/kg, IM), a potent alpha 2-antagonist, within 10 minutes after injection. Peak plasma concentrations were observed after 5 hours, and the elimination half-life was long (about 24 hours).

CONCLUSIONS

All clinical and biological effects observed during the course of amitraz poisoning could be attributed to the parent compound itself and were reversed by low doses of atipamezole. The half-life of amitraz was substantially longer than that in other studies because of the high dose administered.

CLINICAL RELEVANCE

Atipamezole can be administered i.m. to dogs with severe amitraz poisoning to reverse all the effects observed.

Loperamide poisoning in the dog

A retrospective study was conducted of 40 loperamide poisoning cases recorded at the Centre National d'Informations Toxicologiques Veterinaires. An apparent breed susceptibility of Collie dogs was observed. Neurologic disturbances (ataxia and prostration) were significant clinical findings. Treatment with naloxone resulted in rapid reversal of signs without sequelae.

Can household pets be used as reliable monitors of lead exposure to humans?

We investigated the validity of dogs and cats as sentinels of environmental lead exposure to humans. This paper reports findings from a study conducted in Granite City, IL, during the summer of 1991. At this site, a former secondary lead smelter had been in activity for more than 80 years. The smelter was shut down in 1982. The surrounding area was found to be contaminated with lead, with soil lead concentrations above 5000 ppm in some places. The Illinois Department of Public Health conducted a survey in the community to determine the effects of lead on the local population. We sampled dogs and cats owned by these people. Our results suggest that living near a closed lead smelter, with heavy soil contamination, was not associated with high blood lead concentrations in pets, or their owners. There was a significant relationship between BLC (blood lead concentrations), in indoor pets and younger children, which was consistent with our hypothesis that pets could be used to monitor childhood lead exposure. We also found that, when there was one pet with a high BLC in a house, the likelihood of finding one person with a BLC above 10 micrograms/dl was significantly increased.

Anticoagulant poisoning in animals: a simple new high-performance thin-layer chromatographic (HPTLC) method for the simultaneous determination of eight anticoagulant rodenticides in liver samples

The purpose of this study was to develop and evaluate a technique for the analysis of anticoagulant rodenticides in serum and liver samples using a new high-performance thin-layer chromatographic apparatus. Detection limits were estimated at 0.2 micrograms/g in liver extracts for eight different substances. Overall, this technique was repeatable and reproducible. The percent recovery was greater than 87% for each substance. Liver and serum samples of animals known to be exposed to one anticoagulant and showing clinical signs of poisoning were analyzed. Concentrations measured varied between 0.2 and 3 micrograms/g (liver extracts). Only blood samples from one dog could be analyzed. The concentration was 150 ng/mL the first day after admission and 140 ng/mL the following day. Analyses are technically easily and rapidly performed, and they are inexpensive. Therefore, this technique could be a valuable alternative to current high-performance liquid chromatographic methods.

Relationship between soil lead, dust lead, and blood lead concentrations in pets and their owners: evaluation of soil lead threshold values

This paper reports the results of a study conducted in Granite City, Illinois during the months of August through October 1991. The study involved a subpopulation of 77 households having 106 dogs and cats which was a corollary to a major study conducted in humans by the Illinois Department of Public Health to evaluate lead exposure. A secondary lead smelter had been in operation in this town for almost 80 years and was shut down in 1982. Important soil contamination with lead was reported and this paper presents data regarding levels of soil and dust lead and associated blood lead concentrations in animals and their owners in a total of 77 households. Overall, blood lead concentrations (BLC) were low (0-13 micrograms/dl in the animal owners; 0-28 micrograms/dl in pets). There was no significant relationship between soil or dust lead and BLC in humans; however, the relationship was significant in animals. Odds ratios were computed to determine whether 500 or 1000 ppm lead in environmental samples was associated with increased risk of having a high BLC. We could not find any increased risk in humans, while the risk did increase in animals. It is concluded that animals are more at risk than their owners of having a high BLC when exposed to the same contaminated environment and can be used to monitor the bioavailability of lead.

Low blood lead concentration associated with various biomarkers in household pets

A former secondary lead smelter was in operation in Granite City, Ill, until the early 1980s. As a result, the surrounding area is heavily contaminated with lead. Soil concentrations as high as 5,000 ppm have been measured in prior studies. Because of growing concerns about health defects associated with low levels of lead exposure in human beings, a major study has been conducted on people living in the area. The study reported here was a corollary to the human exposure study. Lead concentration was determined in 84 dogs and 26 cats in the town and ranged between < 5 and 28 micrograms/dl. None of the dogs had clinical signs of lead poisoning. The CBC and serum biochemical values did not indicate many significant differences between dogs with a high (> or = 10 micrograms/dl) or low blood lead concentration (BLC). Hemoglobin concentrations were lower, and WBC counts were higher in dogs and cats with higher BLC, but they were still within reference ranges. Free erythrocyte protoporphyrin concentration was determined. Normal values appeared to be similar for dogs and cats. Only animals with BLC > or = 20 micrograms/dl were found to have somewhat increased concentration of free erythrocyte protoporphyrin. delta-Aminolevulinic acid dehydratase activity was measured and found to be negatively correlated with BLC. The relation was strong, even at low BLC (5 to 10 micrograms/dl) in both species. Age or sex difference was not observed. Therefore, biological changes associated with low BLC were limited to BLC in the 10- to 30-micrograms/dl range.

Case reports of lead poisoning in dogs from the National Animal Poison Control Center and the Centre National D'Informations Toxicologiques, Veterinaires: anecdotes or reality?

This paper presents case reports of lead toxicoses from 2 major animal poison control centers in Europe and North America, gathered from 1985 through 1989. All results examined here involved cases assessed as "toxicosis" or "suspected toxicosis" by the National Animal Poison Control Center (NAPCC) or the Centre National d'Informations Toxicologiques Veterinaries (CNITV). 537 cases were reported to the NAPCC, most of them concerning dogs (59%). In France, most of the 362 cases involved cattle (57.2%). There was an increased number of cases reported during late summer and early fall, and a decreased number of cases in November and December, in both centers. Dogs intoxicated were predominantly young animals (60% were less than 2 years old). No sex difference was noted. Pure bred dogs appeared more often involved than mixed-breed ones, but the breed distribution closely resembles dog breed distribution in the US. The source of lead was usually unknown and, when information was available, paint seemed to be the most common cause of poisoning. Clinical signs reported to the animal poison control centers involved the CNS and GI tract. Results from the French and the American database showed similar trends. They are compared to data from veterinary clinics and veterinary colleges in the US and Australia. In each case, data are very similar to what was reported to the CNITV and the NAPCC. It is concluded that animal poison control centers databases can provide a useful tool for better knowledge of animal poisoning. They can also help identify unexpected toxicologic problems related to drug administration or pesticide use.